ArticleFrontiers in clinical diabetes and healthcare2024

GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks.

Ioannis Ilias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.